N-acetyl cysteine add-on treatment for bipolar II disorder: A subgroup analysis of a randomized placebo-controlled trial

Journal of Affective Disorders

Volumn 129, Issue 1-3, 2011, Pages 317-320

  Magalhaes P V ^a,b   Dean, O M ^b,c   Bush, A I ^b   Copolov, D L ^d   Malhi, G S ^e,f   Kohlmann, K ^b,c   Jeavons, S ^b,g   Schapkaitz, I ^b   Anderson Hunt, M ^b   Berk, M ^b,c  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ROYAL NORTH SHORE HOSPITAL   (Australia)

^g School of Psychological Science   (Australia)

Author keywords

Bipolar disorder; Depression; Mania; n Acetyl cysteine; Oxidative stress; Remission; Treatment

Indexed keywords

ACETYLCYSTEINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM; MOOD STABILIZER; PLACEBO;

ADD ON THERAPY; ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR II DISORDER; BIPOLAR MANIA; CLINICAL ARTICLE; CONTROLLED STUDY; DYSHIDROSIS; FEMALE; FUNCTIONAL ASSESSMENT; HEADACHE; HUMAN; MALE; MOOD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; SIDE EFFECT; THIRST; TREATMENT DURATION;

ACETYLCYSTEINE; ADULT; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 79851512462     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.08.001     Document Type: Article

References (33)

1. A.C. Andreazza, M. Kauer-Sant'Anna, D.J. Bond, F. Kapczinski, L.T. Young, and L.N. Yatham Oxidative stress markers in bipolar disorder: a meta-analysis 2008 7-7 pp.
2. A.C. Andreazza, L. Shao, J.F. Wang, and L.T. Young Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder Archives of General Psychiatry 67 2010 360 368
3. M. Berk Neuroprogression: pathways to progressive brain changes in bipolar disorder International Journal of Neuropsychopharmacology 12 2009 441 445
4. M. Berk, and S. Dodd Bipolar II disorder: a review Bipolar Disorders 7 2005 11 21 (Pubitemid 40227832)
5. M. Berk, H. Plein, and B. Belsham The specificity of platelet glutamate receptor supersensitivity in psychotic disorders Life Sciences 66 2000 2427 2432 (Pubitemid 30314186)
6. M. Berk, G.S. Malhi, P.B. Mitchell, C.M. Cahill, A.C. Carman, D. Hadzi-Pavlovic, M.T. Hawkins, and M. Tohen Scale matters: the need for a Bipolar Depression Rating Scale (BDRS) Acta Psychiatrica Scandinavica 110 2004 39 45
7. M. Berk, G.S. Malhi, C. Cahill, A.C. Carman, D. Hadzi-Pavlovic, M.T. Hawkins, M. Tohen, and P.B. Mitchell The Bipolar Depression Rating Scale (BDRS): its development, validation and utility Bipolar Disorders 9 2007 571 579 (Pubitemid 47365624)
8. M. Berk, D.L. Copolov, O. Dean, K. Lu, S. Jeavons, I. Schapkaitz, M. Anderson-Hunt, and A.I. Bush N-acetyl cysteine for depressive symptoms in bipolar disorder - a double-blind randomized placebo-controlled trial Biological Psychiatry 64 2008 468 475
9. M. Berk, F. Ng, O. Dean, S. Dodd, and A.I. Bush Glutathione: a novel treatment target in psychiatry Trends in Pharmacological Sciences 29 2008 346 351
10. M. Berk, F. Ng, W.V. Wang, J.R. Calabrese, P.B. Mitchell, G.S. Malhi, and M. Tohen The empirical redefinition of the psychometric criteria for remission in bipolar disorder Journal of Affective Disorders 106 2008 153 158 (Pubitemid 350309677)
11. M. Berk, G.S. Malhi, K. Hallam, C.S. Gama, S. Dodd, A.C. Andreazza, B.N. Frey, and F. Kapczinski Early intervention in bipolar disorders: clinical, biochemical and neuroimaging imperatives Journal of Affective Disorders 114 2009 1 13
12. O.M. Dean, M. van den Buuse, A.I. Bush, D.L. Copolov, F. Ng, S. Dodd, and M. Berk A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice Current Medicinal Chemistry 16 2009 2965 2976
13. S. Dodd, O. Dean, D.L. Copolov, G.S. Malhi, and M. Berk N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility Expert Opinion on Biological Therapy 8 2008 1955 1962
14. J. Endicott, J. Nee, W. Harrison, and R. Blumenthal Quality-of-life enjoyment and satisfaction questionnaire-a new measure Psychopharmacology Bulletin 29 1993 321 326 (Pubitemid 23311543)
15. K.N. Fountoulakis An update of evidence-based treatment of bipolar depression: where do we stand? Current Opinion in Psychiatry 23 2010 19 24
16. K.N. Fountoulakis, and E. Vieta Treatment of bipolar disorder: a systematic review of available data and clinical perspectives International Journal of Neuropsychopharmacology 11 2008 999 1029
17. S.H. Jones, G. Thornicroft, M. Coffey, and G. Dunn A brief mental-health outcome scale-reliability and validity of the global assessment of functioning (GAF) British Journal of Psychiatry 166 1995 654 659
18. Kapczinski, F., Dal-Pizzol, F., Teixeira, A.L., Magalhaes, P.V., Kauer-Sant'anna, M., Klamt, F., de Bittencourt Pasquali, M.A., Quevedo, J., Gama, C.S., Post, R., 2010. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol. Psychiatry 15 (8), 784-786.
19. S. Kasper, J.R. Calabrese, G. Johnson, and O. Tajima International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression Journal of Clinical Psychiatry 69 2008 1632 1646
20. M.B. Keller, P.W. Lavori, B. Friedman, E. Nielsen, J. Endicott, P. McDonaldscott, and N.C. Andreasen The longitudinal interval follow-up evaluation-a comprehensive method for assessing outcome in prospective longitudinal studies Archives of General Psychiatry 44 1987 540 548 (Pubitemid 17082095)
21. I. Laux, and A. Nel Evidence that oxidative stress-induced apoptosis by menadione involves Fas-dependent and Fas-independent pathways Clinical Immunology 101 2001 335 344
22. S. Lavoie, M.M. Murray, P. Deppen, M.G. Knyazeva, M. Berk, O. Boulat, P. Bovet, A.I. Bush, P. Conus, D. Copolov, E. Fornari, R. Meuli, A. Solida, P. Vianin, M. Cuenod, T. Buclin, and K.Q. Do Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients Neuropsychopharmacology 33 2008 2187 2199 (Pubitemid 351992093)
23. S.A. Montgomery, and M. Asberg New depression scale designed to be sensitive to change British Journal of Psychiatry 134 1979 382 389 (Pubitemid 9136500)
24. P.L. Morosini, L. Magliano, L. Brambilla, S. Ugolini, and R. Pioli Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning Acta Psychiatrica Scandinavica 101 2000 323 329 (Pubitemid 30173584)
25. K. Moussawi, A. Pacchioni, M. Moran, M.F. Olive, J.T. Gass, A. Lavin, and P.W. Kalivas N-Acetylcysteine reverses cocaine-induced metaplasticity Nature Neuroscience 12 2009 182 189
26. F. Ng, M. Berk, O. Dean, and A.I. Bush Oxidative stress in psychiatric disorders: evidence base and therapeutic implications International Journal of Neuropsychopharmacology 11 2008 851 876
27. H.R. Qian, and Y. Yang Neuron differentiation and neuritogenesis stimulated by N-acetylcysteine (NAC) Acta Pharmacologica Sinica 30 2009 907 912
28. D.V. Sheehan, J. Janavs, R. Baker, K. Harnett-Sheehan, E. Knapp, M. Sheehan, Y. Lecrubier, E. Weiller, T. Hergueta, P. Amorim, L.I. Bonora, and J.P. Lepine MINI-Mini International Neuropsychiatric Interview-English version 5.0.0-DSM-IV Journal of Clinical Psychiatry 59 1998 34 57
29. M.K. Singh, D. Spielman, R. Kelley, D. Alegria, M. Howe, A. Reiss, and K. Chang Neurochemical substrates of risk in pediatric offspring of parents with bipolar disorder Bipolar Disorders 11 2009 80-80
30. M.K. Spearing, R.M. Post, G.S. Leverich, D. Brandt, and W. Nolen Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP Psychiatry Research 73 1997 159 171 (Pubitemid 28088172)
31. D. Welin, L.N. Novikova, M. Wiberg, J.O. Kellerth, and L.N. Novikov Effects of N-acetyl-cysteine on the survival and regeneration of sural sensory neurons in adult rats Brain Research 1287 2009 58 66
32. L.N. Yatham, S.H. Kennedy, A. Schaffer, S.V. Parikh, S. Beaulieu, C. O'Donovan, G. MacQueen, R.S. McIntyre, V. Sharma, A. Ravindran, L.T. Young, A.H. Young, M. Alda, R. Milev, E. Vieta, J.R. Calabrese, M. Berk, K. Ha, and F. Kapczinski Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009 Bipolar Disorders 11 2009 225 255
33. R.C. Young, J.T. Biggs, V.E. Ziegler, and D.A. Meyer Rating-scale for mania-reliability, validity and sensitivity British Journal of Psychiatry 133 1978 429 435